Key Insights
The South Korea diabetes care devices market, valued at $457.06 million in 2025, is projected to experience steady growth, driven by a rising prevalence of diabetes and an aging population. The 3% CAGR indicates a consistent, albeit moderate, expansion through 2033. Key growth drivers include increasing awareness of diabetes management, improved healthcare infrastructure, and the rising adoption of advanced technologies such as continuous glucose monitoring (CGM) systems. The market is segmented into monitoring devices (self-monitoring blood glucose devices and CGM), and management devices (insulin pumps, infusion sets, insulin syringes, cartridges in reusable pens, insulin disposable pens, and jet injectors). The increasing preference for convenient and less invasive monitoring methods like CGMs is expected to fuel segment growth. While the market faces potential restraints such as high device costs and limited insurance coverage, the increasing government initiatives to improve diabetes management and the launch of innovative products are likely to offset these challenges. Leading players like Medtronic, Terumo, Abbott Diabetes Care, and Novo Nordisk are actively involved in product development and market penetration, further intensifying competition. The consistent growth is supported by the expanding diabetic patient population and the growing adoption of advanced treatment options. The market is expected to see significant investments in research and development, which will lead to the introduction of newer, more effective, and user-friendly diabetes care devices in the coming years.
South Korea Diabetes Care Devices Market Market Size (In Million)
The competitive landscape is characterized by a mix of multinational corporations and local players. These companies are focused on enhancing their product portfolios, expanding their distribution networks, and engaging in strategic partnerships to gain a larger market share. The focus on technological advancements, such as improved sensor accuracy and integration with mobile applications, will be crucial for sustained growth in the South Korean market. Furthermore, the government's focus on improving healthcare access and affordability through various initiatives will positively influence market expansion. While precise market share data for individual companies is unavailable, the presence of major global players suggests a significant level of competition and market consolidation. The successful players will be those that effectively address the specific needs of the South Korean diabetic population and navigate the regulatory environment effectively.
South Korea Diabetes Care Devices Market Company Market Share
South Korea Diabetes Care Devices Market: A Comprehensive Report (2019-2033)
This in-depth report provides a comprehensive analysis of the South Korea diabetes care devices market, offering invaluable insights for industry stakeholders, investors, and strategic decision-makers. The report covers the period from 2019 to 2033, with a focus on the 2025-2033 forecast period. Key segments analyzed include monitoring devices (self-monitoring blood glucose devices, continuous glucose monitoring devices, and lancets), and management devices (insulin pumps, infusion sets, insulin syringes, cartridges in reusable pens, insulin disposable pens, and jet injectors). The market size is projected to reach xx Million by 2033, exhibiting a CAGR of xx% during the forecast period.
South Korea Diabetes Care Devices Market Market Structure & Competitive Dynamics
The South Korean diabetes care devices market exhibits a moderately concentrated structure, with a few dominant players and several smaller, specialized companies vying for market share. Key players include Medtronic PLC, Terumo, i-Sens, Novo Nordisk A/S, Sanofi, Abbott Diabetes Care, Arkray, F. Hoffmann-La Roche Ltd, Dexcom, Eli Lilly, and Becton Dickinson. The market share analysis reveals a xx% market concentration for the top 7 players in 2024. The level of innovation is substantial, driven by continuous technological advancements in continuous glucose monitoring (CGM) and insulin pump technologies. The regulatory framework, while relatively supportive of medical device innovation, necessitates rigorous approval processes. Product substitution primarily occurs between different types of glucose monitoring devices and insulin delivery systems. End-user preferences are increasingly shifting towards minimally invasive, user-friendly, and technologically advanced devices. M&A activity in the sector has been relatively modest in recent years, with deal values totaling approximately xx Million in the period 2019-2024.
- Market Concentration: xx% for top 7 players in 2024.
- M&A Deal Value (2019-2024): Approximately xx Million.
- Key Innovation Areas: CGM, Insulin Pump Technology, and connected devices.
South Korea Diabetes Care Devices Market Industry Trends & Insights
The South Korea diabetes care devices market is experiencing significant growth, fueled by the rising prevalence of diabetes, an aging population, and increasing healthcare expenditure. Technological advancements, particularly in CGM and insulin pump technology, are driving market expansion, improving patient outcomes and convenience. Consumer preferences are shifting towards more accurate, less invasive, and user-friendly devices. The market has also witnessed a rise in the adoption of connected health solutions which allows for remote patient monitoring and data analysis. The market's competitive dynamics are shaped by technological innovation, pricing strategies, and regulatory changes. The CAGR for the South Korea diabetes care devices market is projected at xx% between 2025 and 2033. Market penetration of CGM systems remains relatively low but is expected to increase significantly due to its superior accuracy and convenience. The government's focus on disease management and improving healthcare outcomes is further contributing to market growth.
Dominant Markets & Segments in South Korea Diabetes Care Devices Market
The South Korean diabetes care devices market is primarily driven by the increasing prevalence of diabetes and improved healthcare infrastructure. While data on regional dominance within South Korea is limited, the major urban centers are likely to lead the market due to higher healthcare access and awareness.
- Monitoring Devices:
- Self-monitoring Blood Glucose Devices (SMBG): This segment holds a significant market share, driven by its affordability and widespread accessibility.
- Continuous Glucose Monitoring (CGM) Devices: The CGM segment is exhibiting strong growth potential, propelled by superior accuracy and convenience compared to SMBG.
- Lancets: This segment is directly tied to the usage of SMBG devices and thus mirrors its growth trajectory.
- Management Devices:
- Insulin Pumps: Growing adoption driven by increased patient awareness and technological improvements.
- Insulin Syringes, Cartridges, Disposable Pens, and Jet Injectors: These segments remain significant due to their widespread use and established market presence.
- Infusion Sets: The infusion set market is expected to demonstrate steady growth, closely following the trends within the insulin pump segment.
Key Drivers:
- Increasing prevalence of diabetes among the South Korean population.
- Growing awareness of diabetes management and complications.
- Improved healthcare infrastructure and access.
- Government initiatives promoting disease management and prevention.
South Korea Diabetes Care Devices Market Product Innovations
The South Korean diabetes care devices market is characterized by continuous product innovation, focusing on enhanced accuracy, usability, and integration with digital health platforms. Miniaturization, improved sensor technology, and advanced data analytics are key trends. Companies are increasingly developing integrated systems that combine glucose monitoring with insulin delivery, providing a comprehensive diabetes management solution. These innovations are designed to improve patient outcomes, simplify treatment routines, and increase patient adherence to therapy.
Report Segmentation & Scope
This report comprehensively segments the South Korea diabetes care devices market into Monitoring Devices (Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Lancets) and Management Devices (Insulin Pumps, Infusion Sets, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors). Each segment is analyzed in detail, considering growth projections, market size, and competitive dynamics. For example, the CGM segment is projected to achieve a higher CAGR compared to SMBG due to its growing popularity and enhanced clinical benefits. The Insulin Pump segment demonstrates robust growth, however the disposable pens and cartridges market maintains significant volume due to affordability.
Key Drivers of South Korea Diabetes Care Devices Market Growth
Several factors contribute to the growth of the South Korean diabetes care devices market. The rising prevalence of diabetes, coupled with an aging population, is a primary driver. Technological advancements in CGM and insulin pump systems are enhancing accuracy and convenience, leading to increased adoption. Furthermore, government initiatives aimed at improving healthcare access and promoting disease management contribute significantly to market expansion. Favorable reimbursement policies for diabetes care devices also fuel market growth.
Challenges in the South Korea Diabetes Care Devices Market Sector
Despite strong growth potential, the South Korea diabetes care devices market faces challenges. High device costs and limited insurance coverage can hinder accessibility, particularly for low-income individuals. Stringent regulatory approvals can cause delays in product launches. Intense competition from both domestic and international players also exerts pressure on pricing and profit margins. The fluctuations in raw material prices can impact production costs and profitability.
Leading Players in the South Korea Diabetes Care Devices Market Market
- Medtronic PLC (Medtronic PLC)
- Terumo (Terumo)
- i-Sens
- Novo Nordisk A/S (Novo Nordisk A/S)
- Sanofi (Sanofi)
- Abbott Diabetes Care (Abbott Diabetes Care)
- Arkray
- F. Hoffmann-La Roche Ltd (F. Hoffmann-La Roche Ltd)
- Dexcom (Dexcom)
- Eli Lilly (Eli Lilly)
- Becton Dickinson (Becton Dickinson)
Key Developments in South Korea Diabetes Care Devices Market Sector
- May 2022: EOFlow, a provider of wearable drug delivery solutions, launched the iOS version of 'Narsha,' a smartphone application for wearable insulin pumps in Korea. This development enhanced the usability and accessibility of insulin pumps.
- January 2023: Adela, an online seller of Abbott Freestyle Libre in Korea, announced a 10% price increase due to rising raw material costs and inflation. This highlights the impact of macroeconomic factors on the market.
Strategic South Korea Diabetes Care Devices Market Market Outlook
The South Korea diabetes care devices market presents substantial growth opportunities driven by unmet clinical needs, technological advancements, and supportive government policies. Strategic focus should be placed on developing innovative, user-friendly devices that address the specific needs of the South Korean population. Expanding partnerships with healthcare providers and enhancing digital health integration can drive further market penetration. Companies that prioritize patient centricity and embrace technological disruptions are poised to capture significant market share in the years to come.
South Korea Diabetes Care Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring Devices
- 1.2.1. Sensors
- 1.2.2. Durables (Receivers and Transmitters)
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
South Korea Diabetes Care Devices Market Segmentation By Geography
- 1. South Korea
South Korea Diabetes Care Devices Market Regional Market Share
Geographic Coverage of South Korea Diabetes Care Devices Market
South Korea Diabetes Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 3.00% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Self-Monitoring Blood Glucose Devices occupy the highest market share in the monitoring devices segment in South Korea Diabetes Care Devices Market in the current year
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. South Korea Diabetes Care Devices Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring Devices
- 5.1.2.1. Sensors
- 5.1.2.2. Durables (Receivers and Transmitters)
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. South Korea
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- 6.2. Company Profiles
- 6.2.1 Medtronic PLC
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Terumo
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 i-Sens
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Novo Nordisk A/S
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Sanofi
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Abbott Diabetes Care
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Arkray
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 F Hoffmann-La Roche Ltd
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 Dexcom
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Eli Lilly*List Not Exhaustive 7 2 Company Share Analysi
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.11 Becton Dickinson
- 6.2.11.1. Overview
- 6.2.11.2. Products
- 6.2.11.3. SWOT Analysis
- 6.2.11.4. Recent Developments
- 6.2.11.5. Financials (Based on Availability)
- 6.2.1 Medtronic PLC
List of Figures
- Figure 1: South Korea Diabetes Care Devices Market Revenue Breakdown (Million, %) by Product 2025 & 2033
- Figure 2: South Korea Diabetes Care Devices Market Share (%) by Company 2025
List of Tables
- Table 1: South Korea Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 2: South Korea Diabetes Care Devices Market Volume K Units Forecast, by Monitoring Devices 2020 & 2033
- Table 3: South Korea Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 4: South Korea Diabetes Care Devices Market Volume K Units Forecast, by Management Devices 2020 & 2033
- Table 5: South Korea Diabetes Care Devices Market Revenue Million Forecast, by Region 2020 & 2033
- Table 6: South Korea Diabetes Care Devices Market Volume K Units Forecast, by Region 2020 & 2033
- Table 7: South Korea Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2020 & 2033
- Table 8: South Korea Diabetes Care Devices Market Volume K Units Forecast, by Monitoring Devices 2020 & 2033
- Table 9: South Korea Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2020 & 2033
- Table 10: South Korea Diabetes Care Devices Market Volume K Units Forecast, by Management Devices 2020 & 2033
- Table 11: South Korea Diabetes Care Devices Market Revenue Million Forecast, by Country 2020 & 2033
- Table 12: South Korea Diabetes Care Devices Market Volume K Units Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the South Korea Diabetes Care Devices Market?
The projected CAGR is approximately 3.00%.
2. Which companies are prominent players in the South Korea Diabetes Care Devices Market?
Key companies in the market include Medtronic PLC, Terumo, i-Sens, Novo Nordisk A/S, Sanofi, Abbott Diabetes Care, Arkray, F Hoffmann-La Roche Ltd, Dexcom, Eli Lilly*List Not Exhaustive 7 2 Company Share Analysi, Becton Dickinson.
3. What are the main segments of the South Korea Diabetes Care Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 457.06 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Self-Monitoring Blood Glucose Devices occupy the highest market share in the monitoring devices segment in South Korea Diabetes Care Devices Market in the current year.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
January, 2023: Adela (Online Selling website for Abbott Free Style Libre in Korea) announced that the freestyle libre selling price is expected to be raised by 10% in Korea, due to continuous raise in raw materials and inflation.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Units.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "South Korea Diabetes Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the South Korea Diabetes Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the South Korea Diabetes Care Devices Market?
To stay informed about further developments, trends, and reports in the South Korea Diabetes Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence